You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR SECUKINUMAB

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for secukinumab

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00685399 ↗	Safety and Efficacy of AIN457 in Noninfectious Uveitis	Completed	Novartis Pharmaceuticals	Phase 2	2008-06-01	This study was performed to evaluate the efficacy and safety of AIN457 for patients with active uveitis that requires systemic immunosuppression.
NCT00805480 ↗	Multiple-loading Dose Regimen Study in Patients With Chronic Plaque-type Psoriasis	Completed	Novartis Pharmaceuticals	Phase 2	2008-12-01	Loading dose, four arm, double-blind, parallel group, placebo-controlled study comparing single and multiple doses of AIN457 to placebo in patients with a diagnosis of moderate to severe chronic plaque psoriasis.
NCT00928512 ↗	Efficacy, Safety and Tolerability of AIN457 in Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX)	Completed	Novartis Pharmaceuticals	Phase 2	2009-07-01	This study will assess at Week 16 the efficacy and safety of AIN457 at different doses in patients with active RA despite stable MTX therapy. Treatment will continue up to Week 48 with a safety follow-up at Week 60 to assess the long term efficacy and safety of AIN457 treatment in combination with MTX in RA.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for secukinumab

Condition Name

Chart
Table

Condition Name for secukinumab
Intervention	Trials
Psoriasis	23
Psoriatic Arthritis	15
Plaque Psoriasis	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for secukinumab
Intervention	Trials
Psoriasis	52
Arthritis	22
Arthritis, Psoriatic	19
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for secukinumab

Trials by Country

Map
Table

Trials by Country for secukinumab
Location	Trials
United States	681
Spain	139
Italy	105
Japan	100
United Kingdom	100
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for secukinumab
Location	Trials
California	44
Texas	42
Florida	34
New York	34
Missouri	26
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for secukinumab

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for secukinumab
Clinical Trial Phase	Trials
Phase 4	28
Phase 3	59
Phase 2	25
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for secukinumab
Clinical Trial Phase	Trials
Completed	67
Recruiting	21
Not yet recruiting	15
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for secukinumab

Sponsor Name

Chart
Table

Sponsor Name for secukinumab
Sponsor	Trials
Novartis Pharmaceuticals	79
Novartis	12
Icahn School of Medicine at Mount Sinai	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for secukinumab
Sponsor	Trials
Industry	108
Other	51
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.